A Study to Evaluate the Efficacy & Safety of Apremilast (CC-10004) in

See also
Status	Clinical Trial	Phase
Completed	`NCT03274648` - Dietary Interventions and Butyrate Production in Behçet's Patients	N/A
Terminated	`NCT01693653` - Tocilizumab for the Treatment of Behcet's Syndrome	Phase 2
Completed	`NCT04961463` - Evaluation of the Psychoeducation Program Given to Behcet's Patients in the Context of the Roy Adaptation Model	N/A
Completed	`NCT05142995` - Sleep Related Breathing Disorders, Anxiety, Depression and Quality of Life Assessment in Behcet's Disease
Recruiting	`NCT00931957` - Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease	N/A
Completed	`NCT03514056` - Frequency of Fibromyalgia in Behcet Disease
Not yet recruiting	`NCT03771768` - Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease	N/A
Terminated	`NCT03554161` - Tocilizumab for the Treatment of Refractory Behcet's Uveitis	Phase 2
Recruiting	`NCT04738864` - Neuro-ultrasound Assessment in Behcet's Disease	N/A
Completed	`NCT03264391` - Evaluation of Macular Vascular Changes in Behcet's Disease Using Optical Coherence Tomography Angiography
Completed	`NCT04386824` - Erectile Dysfunction in Patients With Non Ocular Behçet's Disease
Completed	`NCT03962335` - Gut Microbiota and Behcet's Syndrome: a Dietary Intervention Trial (MAMBA Study)	N/A
Completed	`NCT01532570` - Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions	Phase 3
Not yet recruiting	`NCT04186559` - Topical Pentoxifylline Gel on Behcet's Disease Genital Ulcers	Phase 2
Terminated	`NCT04218565` - Golimumab for the Treatment of Refractory Behcet's Uveitis	Phase 2
Not yet recruiting	`NCT03747354` - Assessment of Disease Activity in Behcet by Complete Blood Count	N/A
Recruiting	`NCT05200715` - AutoInflammatory Disease Alliance Registry (AIDA)
Completed	`NCT05098678` - Zinc Supplementation and Behçet's Syndrome	N/A
Completed	`NCT00483184` - Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease	Phase 2
Completed	`NCT05032248` - Uses of Tacrolimus in Behcet Disease	N/A

NCT number	NCT00866359
Study type	Interventional
Source	Amgen
Contact
Status	Completed
Phase	Phase 2
Start date	August 1, 2009
Completion date	May 1, 2012

A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms